Most Read Articles
Pearl Toh, 2 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
5 days ago
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.

Major fractures contribute to increased mortality in dialysis patients

27 Feb 2020

Major fractures (MFs) are prevalent in dialysis patients and appear to be strongly related to heightened risk of death, a study reports.

The analysis included 9,714 incident dialysis patients (mean age, 68 years; 67 percent men). Researchers examined the incidence, predictors and clinical outcomes associated with first MFfirst (in hip, spine, humerus and forearm) occurring after initiation of dialysis using flexible parametric hazard models, Fine-Gray and time-dependent analyses.

Over a median follow-up of 2.2 years, a total of 835 MFfirst and 470 hip fractures occurred. The crude incidence rates were 23.7 and 13.3 per 1,000 patient-years, respectively. The multivariate-adjusted fracture incidence rates showed a gradual increase after dialysis initiation and were higher by 47 percent in women.

Significant factors associated with increased MFfirst risk included female sex, higher age, comorbidity and previous history of MF, whereas peritoneal dialysis (vs haemodialysis) exerted a protective effect.

The adjusted fracture incidence rate of MFfirst during the first 90 days following dialysis initiation was higher in patients with vs without previous history of MF.

MFfirst emerged as an independent predictor of increased mortality both from all-cause (sub-distribution hazard ratio [SHR], 1.67, 95 percent confidence interval [CI], 1.47–1.91) and cardiovascular disease (SHR, 1.49, 95 percent CI, 1.22–1.84).

Adjusted mortality rate was higher following hip fractures than other types of MF. Mortality following MFfirst was highest during the first 6 months of follow-up, as indicated in spline curves.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 2 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
5 days ago
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.